To Top
Loading Events

« All Events

  • This event has passed.

CME: Tensoynovial Giant Cell Tumor: New systemic treatment options to address unmet needs

October 24, 2019 @ 11:00 am - 1:00 pm

Join us on Thursday, October 24, for two live sessions on Tenosynovial Giant Cell Tumor. Session 1 of this series will focus on defining the type and prevalence of TGCT and the risks inherent to surgery. Listen as a patient takes part of the panel and shares their experiences and journey through care from diagnosis to management. Session 2 will discuss the impact of new and emerging targeted agents on the standard of care of patients who are not candidates for surgery.

Educational Objectives:

  • Discuss the signs and symptoms of localized and diffuse types of TGCT, as well as appropriate tests to confirm a diagnosis
  • Identify patients with TGCT who are likely versus not likely to benefit from surgery
  • Describe the mechanism of action, benefits and adverse events of new and emerging pharmacologic treatment options for TGCT patients who are symptomatic and not candidates for surgery

Featured Speakers:

William D. Tap, MD

Chief, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center

John H. Healey, MD, FACS

Stephen McDermott Chair in Surgery, Chief, Orthopaedic Surgery

Memorial Sloan Kettering Cancer Center, Professor of Orthopaedic Surgery, Weill Cornell Medical College

Watch top experts via streaming video, get the latest medical science, and earn AMA PRA Category 1 Credit™.